The evolving challenge of therapy-related myeloid neoplasms.
about
Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis.Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell ActivityRelationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions.Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.CD34(+) therapy-related acute promyelocytic leukemia in a patient previously treated for breast cancer.Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Preleukemia: one name, many meanings.A focused review of hematopoietic neoplasms occurring in the therapy-related setting.Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients.Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.Therapy-related myeloid neoplasms in children and adolescents.Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis.Preexisting TP53 mutation in therapy-related acute myeloid leukemia.Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature.Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.Acute myeloid leukemia
P2860
Q33439914-AEACF515-FB41-4D04-BFC2-7EC85D9B8835Q35126237-121F30D5-5640-4857-BAAD-08E726BE3242Q36080036-6DCE2966-9269-416E-8EDF-D5C46F515691Q36750533-6D7824CF-213C-46E3-BF8B-1E9CD520F8B4Q37002149-3ADC9881-27FA-4EA6-8DD6-F846EF480EC0Q37044055-E880E4BA-A01E-4C6E-8748-6AA62DC1C17BQ37362538-4670C054-450B-437D-87C8-0F3B01D673E7Q37624593-DB92F325-3684-4725-8DDC-0EA991B2C917Q37683379-D6D1C93A-CBC2-4805-8AD7-BB8E82E637E4Q38239675-1BA1B100-2998-4FC5-B093-04151E246BE5Q38683856-5203C4C5-2CB2-4A4F-8E66-617F6AB427C1Q38984169-226FBC65-706D-4AEE-BFE2-222D66361CDEQ41876204-F99C35C0-25A0-42C8-8FB2-CC71A8793331Q42147158-20D1A8E8-0701-451A-BE80-AC65C9A7CB40Q43132538-45E8FE02-ABFC-4959-9353-73F267ADF73BQ44355651-8CAA9905-602F-4AD8-A691-E37EC254FBE9Q48326336-BB876B78-F360-42E8-A3FE-BC4FCCFE733CQ49233865-FC8BD611-EFF6-4A33-A6C7-1445E060E230Q49702436-F68BBF26-3012-407C-BFDE-22CB1DBA5050Q58481761-425D524D-9ED1-41E8-BFAF-5630732AB371
P2860
The evolving challenge of therapy-related myeloid neoplasms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The evolving challenge of therapy-related myeloid neoplasms.
@en
The evolving challenge of therapy-related myeloid neoplasms.
@nl
type
label
The evolving challenge of therapy-related myeloid neoplasms.
@en
The evolving challenge of therapy-related myeloid neoplasms.
@nl
prefLabel
The evolving challenge of therapy-related myeloid neoplasms.
@en
The evolving challenge of therapy-related myeloid neoplasms.
@nl
P2860
P1476
The evolving challenge of therapy-related myeloid neoplasms.
@en
P2093
Jane E Churpek
P2860
P304
P356
10.1016/J.BEHA.2013.09.001
P577
2013-10-01T00:00:00Z